4//SEC Filing
Farzaneh-Far Ramin 4
Accession 0001104659-20-035491
CIK 0001481512other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:00 PM ET
Size
12.9 KB
Accession
0001104659-20-035491
Insider Transaction Report
Form 4
Farzaneh-Far Ramin
Chief Medical Officer
Transactions
- Sale
COMMON STOCK
2020-03-16$45.16/sh−10,595$478,521→ 7,132 total - Exercise/Conversion
Stock Options (Right to buy)
2020-03-16−9,206→ 73,654 totalExercise: $5.60Exp: 2026-08-16→ Common Stock (9,206 underlying) - Exercise/Conversion
COMMON STOCK
2020-03-16$5.60/sh+1,389$7,778→ 8,521 total - Exercise/Conversion
COMMON STOCK
2020-03-16$5.60/sh+9,206$51,554→ 17,727 total - Exercise/Conversion
Stock Options (Right to buy)
2020-03-16−1,389→ 11,110 totalExercise: $5.60Exp: 2026-08-16→ Common Stock (1,389 underlying)
Footnotes (4)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $44.85 to $45.82. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These stock options vest over a four (4) year period in 48 equal monthly installments at the end of each month following August 16, 2016.
- [F4]These stock options vest a four (4) year period with the first twenty five percent (25%) of such shares vesting on the first anniversary of July 11, 2016, and the remaining shares vesting in equal monthly installments at the end of each month following the first anniversary of July 11, 2016 over the following thirty six (36) months, subject to the terms set forth in the applicable equity agreement.
Documents
Issuer
Ra Pharmaceuticals, Inc.
CIK 0001481512
Entity typeother
Related Parties
1- filerCIK 0001688195
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:00 PM ET
- Size
- 12.9 KB